FDA.reportPublic FDA data

fingolimod 0.25 MG Disintegrating Oral Tablet [Tascenso]

RxCUI
2610302
RxNorm name
fingolimod 0.25 MG Disintegrating Oral Tablet [Tascenso]
Display name
fingolimod 0.25 MG Disintegrating Oral Tablet [Tascenso]
Full name
fingolimod 0.25 MG Disintegrating Oral Tablet [Tascenso]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TASCENSO ODTFINGOLIMOD LAURYL SULFATECycle Pharmaceuticals Ltdbf8e7f89-ea09-43c7-a7eb-e447243507212026-01-08Warnings, Adverse reactionsExact identifier
rxcui: 2610302

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
bf8e7f89-ea09-43c7-a7eb-e44724350721fingolimod 0.25 MG Disintegrating Oral Tablet [Tascenso]SBD8These highlights do not include all the information needed to use TASCENSO ODT ® safely and effectively. See full prescribing information for TASCENSO ODT. TASCENSO ODT (fingolimod) orally disintegrating tablets Initial U.S. Approval: 201020260108
bf8e7f89-ea09-43c7-a7eb-e44724350721Tascenso 0.25 MG (as fingolimod lauryl sulfate 0.47 MG) Disintegrating Oral TabletSY8These highlights do not include all the information needed to use TASCENSO ODT ® safely and effectively. See full prescribing information for TASCENSO ODT. TASCENSO ODT (fingolimod) orally disintegrating tablets Initial U.S. Approval: 201020260108
bf8e7f89-ea09-43c7-a7eb-e44724350721Tascenso ODT 0.25 MG Disintegrating Oral TabletPSN8These highlights do not include all the information needed to use TASCENSO ODT ® safely and effectively. See full prescribing information for TASCENSO ODT. TASCENSO ODT (fingolimod) orally disintegrating tablets Initial U.S. Approval: 201020260108